HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marina Montagnani Marelli Selected Research

LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)

12/2020Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions.
1/2015Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
1/2014Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.
10/2012GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies.
3/2011Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
10/2010Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.
5/2009Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.
5/2009Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation.
8/2008Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
1/2007Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marina Montagnani Marelli Research Topics

Disease

20Neoplasms (Cancer)
06/2021 - 08/2002
15Prostatic Neoplasms (Prostate Cancer)
06/2021 - 09/2002
10Melanoma (Melanoma, Malignant)
12/2019 - 08/2002
3Carcinoma (Carcinomatosis)
01/2007 - 10/2004
2Neoplasm Metastasis (Metastasis)
12/2019 - 03/2006
1Inflammation (Inflammations)
01/2021
1Chronic Disease (Chronic Diseases)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
05/2009
1Glioma (Gliomas)
05/2009
1Carcinogenesis
11/2007

Drug/Important Bio-Agent (IBA)

12Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2020 - 08/2002
12LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
12/2020 - 08/2002
9AndrogensIBA
06/2021 - 09/2002
6Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2002
4Biological ProductsIBA
12/2020 - 11/2007
4Hormones (Hormone)IBA
01/2016 - 08/2002
3TocotrienolsIBA
05/2019 - 01/2016
2ResveratrolIBA
02/2019 - 01/2019
2Docetaxel (Taxotere)FDA Link
01/2018 - 01/2014
2Estrogen ReceptorsIBA
01/2016 - 01/2015
2GonadotropinsIBA
01/2015 - 12/2003
2ClusterinIBA
07/2011 - 11/2007
2Matrix Metalloproteinases (MMPs)IBA
07/2011 - 08/2008
2Leuprolide (Lupron)FDA LinkGeneric
03/2011 - 01/2007
2Protein Isoforms (Isoforms)IBA
10/2010 - 11/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010 - 12/2003
2Messenger RNA (mRNA)IBA
05/2009 - 08/2002
2Cell Adhesion MoleculesIBA
08/2008 - 12/2003
2Complementary DNA (cDNA)IBA
11/2007 - 12/2003
2Integrin alphaVbeta3IBA
01/2007 - 03/2006
2Insulin-Like Growth Factor I (IGF-1)IBA
01/2007 - 03/2006
2Orphan Nuclear ReceptorsIBA
10/2004 - 09/2002
1AlkaloidsIBA
06/2021
1LactamsIBA
06/2021
1quinolineIBA
06/2021
1pyrrolidineIBA
06/2021
1CytokinesIBA
01/2021
1Adenosine Triphosphate (ATP)IBA
12/2019
1PhytochemicalsIBA
12/2019
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
12/2019
1PolyphenolsIBA
02/2019
1TeaIBA
02/2019
1CurcuminIBA
02/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1AntioxidantsIBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2019
1ferulic acid (sodium ferulate)IBA
01/2019
1sesaminIBA
01/2019
1CholesterolIBA
01/2019
1Palm OilIBA
05/2018
1Phytoestrogens (Phytoestrogen)IBA
01/2016
1LigandsIBA
01/2016
1Vitamin EFDA LinkGeneric
01/2016
1Estrogens (Estrogen)FDA Link
01/2016
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2015
1OximesIBA
01/2015
1Cytostatic AgentsIBA
01/2015
1gonadotropin-releasing hormone-IIIIBA
01/2015
1SteroidsIBA
10/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2010
1Peptides (Polypeptides)IBA
05/2009
1His(5)-Trp(7)-Tyr(8)- LHRHIBA
05/2009
1Integrin alpha3IBA
08/2008
1Culture MediaIBA
08/2008
1Chemotactic FactorsIBA
08/2008
1Laminin (Merosin)IBA
08/2008
1Phosphotransferases (Kinase)IBA
01/2007
1Tyrosine (L-Tyrosine)FDA Link
01/2007
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2004
1Fatty Acids (Saturated Fatty Acids)IBA
10/2004
1Dietary Fats (Dietary Fat)IBA
10/2004
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2004
1AcidsIBA
10/2004
15-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
10/2004
1Epidermal Growth Factor (EGF)IBA
12/2003
1EnzymesIBA
12/2003
1CGP 52608IBA
09/2002
1Fibronectins (Fibronectin)IBA
09/2002
1IntegrinsIBA
09/2002
1Goserelin (Zoladex)FDA Link
08/2002
1matrigelIBA
08/2002

Therapy/Procedure

6Castration
06/2021 - 10/2012
6Therapeutics
12/2020 - 08/2008
3Drug Therapy (Chemotherapy)
01/2018 - 08/2002